For Industry

The KRF will be working closely with partners in the pharmaceutical and biotech industry to advance the next generation of treatments for keloid. In an effort to bring the most promising treatments to patients, KRF will champion collaboration between industry and academia to speed the development and implementation of innovative treatments for keloid.

KRF is intending to have a Keloid Genomics Portal, the world's only keloid specific repository of genomic data, which will provide the scientific community with open access to high-resolution genomic data from the KRF Genomics Initiative prior to publication and in near real-time.

All of this requires commitment from our members and our ability to raise the needed funds to advance the research in keloid.